Analysis of patient data reveals significantly higher ATF4 mRNA levels in neuroblastoma tumors with MYCN amplification [80] and higher ATF4 expression is associated with poor prognosis in neuroblastoma patients [81]. Here, MYCN is linked to neuroblastoma.